ArticleOrphanet journal of rare diseases2014
Relapsing polychondritis: clinical presentations, disease activity and outcomes.
Article in Orphanet journal of rare diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 39 citations in OpenAlex.
- Clinical Manifestations and Treatment in Patients With Relapsing Polychondritis: A Multicenter Observational Cohort Study.ACR open rheumatology · 2025Article
- Recurrent lymphocytic meningitis and progressive dementia: manifestations of relapsing polychondritis: a case report.BMC neurology · 2025Article
- A multicenter study of long-term outcomes of relapsing polychondritis in Iran.Scientific reports · 2024Article
- Clinical patterns and the evolution of relapsing polychondritis based on organ involvement: a Chinese retrospective cohort study.Orphanet journal of rare diseases · 2021Article
- Relapsing Polychondritis Requiring Orthotopic Heart Transplant Despite Coronary Artery Bypass and Surgical Aortic Valve Replacement.JACC. Case reports · 2020Article
- Diagnosing relapsing polychondritis remains a common challenge: experience from a Chinese retrospective cohort.Clinical rheumatology · 2020Article
- Relapsing Polychondritis: An Updated Review.Biomedicines · 2018Review
- Patient Perception of Disease-Related Symptoms and Complications in Relapsing Polychondritis.Arthritis care & research · 2018Article
- Multiple Cranial-Nerve Palsies: An Unusual Culprit.Journal of clinical neurology (Seoul, Korea) · 2018Article
- Review
- Article
- Relapsing polychondritis: a chameleon among orphan diseases.Wiener medizinische Wochenschrift (1946) · 2017Review
- Connective Tissue Disorder-Associated Vasculitis.Current rheumatology reports · 2016Review
- Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives.Current rheumatology reports · 2016Review
- A nationwide study of the epidemiology of relapsing polychondritis.Clinical epidemiology · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRelapsing polychondritis is a rare disease characterised by inflammation of cartilaginous and proteoglycan rich structures. As there are only a few published single centre case series from all across the world, we describe our experience with 26 patients at a tertiary centre in north India.
methodsA retrospective study with all patients meeting Damiani and Levine's modification of McAdam's diagnostic criteria. Clinical details, investigations, disease activity assessment [(Relapsing Polychondritis Disease Activity Index (RPDAI)], treatment and outcomes were recorded.
resultsTen men and sixteen women (median age 45 years) met the diagnostic criteria. Auricular chondritis (96%), arthritis (54%), hearing impairment (42%), ocular (42%), dermal (26%), cardiovascular (11%) and laryngotracheal involvement (11%) characterized the clinical presentations. The median RPDAI was 31 (range 9-66). Two patients died during observation. Overall survival was 92.3% (median survival 13.5 years).
conclusionsApart from reduced laryngotracheal involvement, RP in India was clinically similar to recorded patterns elsewhere.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.